SCHEMBL20207489

SCHEMBL20207489

COc1cccc(OC)c1-n1c(NSCCC(O)C2CCCC2)nnc1-c1nc(C)cs1

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 20/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22537315 0.85 APLNR (0.50) APLNR
SCHEMBL20188892 0.84 APLNR (0.64) APLNR
SCHEMBL20188894 0.84 APLNR (0.64) APLNR
SCHEMBL20190179 0.84 APLNR (0.64) APLNR
SCHEMBL20201137 0.82 APLNR (0.51) APLNR
SCHEMBL20201161 0.81 APLNR (0.51) APLNR
SCHEMBL22537256 0.81 APLNR (0.55) APLNR
SCHEMBL20207436 0.78 APLNR (0.58) APLNR
SCHEMBL20207305 0.77 APLNR (0.70) APLNR
SCHEMBL20207255 0.77 APLNR (0.64) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541805-B1 HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS AMGEN INC (US) 2020-10-14 EP disclosed
WO-2018097945-A1 HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS AMGEN INC. (US) 2018-05-31 WO disclosed